A Dose Escalation and Expansion Study of BGB-16673 in Patients with B Cell Malignancies

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-502157-33-00

Acronym

BGB-16673-101

Enrollment

239

Registered

2023-07-11

Start date

2023-09-18

Completion date

Unknown

Last updated

2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

B-Cell Malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Italy, Spain, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026